The Propoxyphene Napsylate and Aceta, cataloged under National Stock Number 6505-01-040-2286, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Eli Lilly and Company. Government technical data includes 7 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-040-2286 |
| Primary Part Number | NDC00002-0363-33DARVOCET-N 100 |
| Item Name | Propoxyphene Napsylate and Aceta |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Eli Lilly and Company |
| Status | ACTIVE |
| Administration | ORAL |
| Primary Container Content Quantity | 10.000 TABLETS |
| Secondary Container Type | BOX |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | STRIP |
| Active Medicament Medicinal Strength | 650.000 MILLIGRAMS ACETAMINOPHEN ACTIVE INGREDIENT |
| Total Primary Container Quantity | 10 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC00002-0363-33DARVOCET-N 100 PRIMARY | Eli Lilly and Company (USA) |
| NDC51079-0322-21 PRIMARY | Mylan Institutional Inc Dba Mylan Institutional (USA) |
| Reference | Meaning |
|---|---|
| NDC00093-0590-45 | 3/2 Design control — primary reference U.S. Government activity |
NSN 6505-01-040-2286 is a Propoxyphene Napsylate and Aceta, manufactured by Eli Lilly and Company, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-040-2286 has 2 manufacturer part numbers on file: NDC00002-0363-33DARVOCET-N 100 (Eli Lilly and Company), NDC51079-0322-21 (Mylan Institutional Inc Dba Mylan Institutional).
Key specifications for NDC00002-0363-33DARVOCET-N 100: Administration: ORAL; Primary Container Content Quantity: 10.000 TABLETS; Secondary Container Type: BOX; Medical Designation and Grade: UNITED STATES PHARMACOPEIA. 7 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.